Logo
x

Search category

Subscribe Now

PassPort Technologies

PassPort Technologies Reports Data from the P-I Study of Zolmitriptan Transdermal Microporation System to Treat Acute Migraine

PassPort Technologies Reports Data from the P-I Study of Zolmitriptan Transdermal Microporation System to Treat Acute Migraine

  • April 1, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.